Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Emulsi Biotech has raised $743K in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2026.
Emulsi Biotech's investors include BSV Ventures, Vinnova, Almi Värmland.
Emulsi Biotech is headquartered in Lund, Sweden.
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Emulsi Biotech is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emulsi Biotech — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/emulsi-biotech. Accessed September 29, 2026.
VCBacked. (2026). Emulsi Biotech — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/emulsi-biotech
{{cite web |title=Emulsi Biotech — Funding & Investors |url=https://www.vcbacked.co/company/emulsi-biotech |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated